1. Home
  2. GROV vs TARA Comparison

GROV vs TARA Comparison

Compare GROV & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.21

Market Cap

55.0M

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$5.30

Market Cap

165.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
TARA
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.0M
165.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GROV
TARA
Price
$1.21
$5.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$1.60
$20.40
AVG Volume (30 Days)
54.6K
1.3M
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,808,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.02
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$2.77
52 Week High
$1.95
$7.82

Technical Indicators

Market Signals
Indicator
GROV
TARA
Relative Strength Index (RSI) 38.12 42.48
Support Level $1.22 $5.03
Resistance Level $1.35 $6.37
Average True Range (ATR) 0.06 0.41
MACD -0.01 -0.17
Stochastic Oscillator 17.50 13.74

Price Performance

Historical Comparison
GROV
TARA

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Share on Social Networks: